This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed features (bipolar mania), with or without psychotic symptoms, according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).
Bipolar Disorder, Manic
This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed features (bipolar mania), with or without psychotic symptoms, according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).
Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania
-
Clinical Site, Rogers, Arkansas, United States, 72758
Clinical Site, Bellflower, California, United States, 90706
Clinical Site, Culver City, California, United States, 90230
Clinical Site, Garden Grove, California, United States, 92845
Clinical Site, Lemon Grove, California, United States, 91945
Clinical Site, Montclair, California, United States, 91763
Clinical Site, Hallandale Beach, Florida, United States, 33009
Clinical Site, Hialeah, Florida, United States, 33016
Clinical Site, Miami Gardens, Florida, United States, 33056
Clinical Site, Miami Lakes, Florida, United States, 33016
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 75 Years
ALL
No
Intra-Cellular Therapies, Inc.,
2026-04